The release of TGFβ may contribute to metastasis in an autocrine and/or paracrine manner by leading to EMT of tumour cells, inhibiting cell adhesion, inducing immunosuppression and angiogenesis and promoting the degradation of the extracellular matrix. Here, TGFB1 is linked to neoplasm.